NAME A/Prof. David Lynn
CANCER TYPE General
INSTITUTION South Australian Health and Medical Science Institute
STATE South Australia
GRANT TYPE $50,000
PROJECT TYPE Research
Reducing the toxicity associated with agonistic antibody cancer immunotherapies by targeting the gut microbiota.
"To investigate how the gut microbiota influences immune responses to cancer immunotherapies we have established a unique collaboration between leading researchers in the Infection and Immunity, and Cancer, Themes at the South Australian Health and Medical Research Institute (SAHMRI)."
- A/Prof. David Lynn, South Australian Health and Medical Science Institute